He emphasized that by reintroducing these products to the compounding list, a legal market could be established, which would ensure that consumers receive quality products made from safely sourced ingredients
Although these changes are generally not clinically significant in healthy individuals, they could pose a greater risk in populations predisposed to metabolic disorders, such as prediabetes or type 2 diabetes
Regarding the primary endpoint, all doses of tirzepatide were superior in comparison to semaglutide
HHS has announced that GHK-Cu is expected to return to Category 1, which would restore the compounding pathway for injectable formulations. BPC-157 On July 23, 2026, PCAC voted to recommend adding BPC-157 to the 503A Bulk Drug Substances List
Because NAD is a supplement, its not regulated by the FDA and claims around efficacy dont have to be proven (which is required of prescription medications)
And they're like, that's because you're not exercising enough because you're a mom and everything was, you're a mom